Ripped off? Why the EU is paying a premium for new Covid shots

The bloc had a tricky start to its vaccination campaign, and things haven’t become any easier since, writes Francesco Guarascio

File photo dated 19/02/21 of a Pfizer/BioNTech Covid-19 vaccine being prepared. 

The European Union has agreed to pay a premium on new orders of Covid-19 vaccines because it is requiring tougher terms to be met, European officials said, as the bloc tries to protect supplies after a rocky start to its vaccination campaign.

The higher price is less than the US has agreed to pay in its latest order in July.